Robotics

PATH stock: Can UiPath keep its RPA lead?

Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. You should consider whether you understand how spread bets, CFDs, OTC options or any of our other products work and whether you can afford to…

PATH stock: Can UiPath keep its RPA lead?

Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. You should consider whether you understand how spread bets, CFDs, OTC options or any of our other products work and whether you can afford.

You should consider whether you can afford to take the high risk of losing your money. UiPath [PATH] is a leading automation software maker whose products and services free up workers from monotonous tasks by streamlining workflows and orchestrating robots.

What Happened

The firm added a string to its agent orchestration bow in June with the launch of Maestro Case, an automation platform for handling messy, unpredictable business work, including customer disputes and fraud investigations. One investor shorting the software theme was former OpenAI.

Advertisement
  • Here, we unpack the outlook for UiPath following its Q2 2027 earnings on 3 September, and ask what might move PATH stock in the near term.

  • According to the press release, early deployments indicate that Maestro Case could increase the number of cases resolved that do not require human intervention three to five times, while the platform has reduced the.

  • Software stocks have been heavily shorted in 2026 amid fears that AI could disrupt traditional software-as-a-service models.

Key Details

However, when his hedge fund Situational Awareness suffered huge losses – and eventually faced liquidation – he was forced to unwind his positions. This caused the software theme to rally.

  • As a result, PATH stock may be down 7.32% since the start of the year to 4 September, but it is up 37.59% in the past six months and 16.4% in the past month.

  • Despite these gains, the share price cratered 16.63% in reaction to the Q2 2027 earnings reported after the market closed on 3 September.

  • PATH stock initially jumped nearly 10% in reaction to the results, which beat revenue expectations and raised full-year guidance, then quickly swung the other way, likely due to concerns about subscriptions.

Why It Matters

The bad news: Net new ARR in Q2 2027 was $37m, down from $49m in Q1 2027 and $70m in Q4 2026. This would imply that fewer new customers are signing up for a UiPath subscription.

  • The good news: revenue for the three months to 31 July rose 13% to $410m, comfortably beating the $397.8m analysts had expected.

  • Full-year guidance was raised to a range of $1.789bn-1.794bn from a previous forecast of $1.776bn-1.781bn.

What Reports Say

Coverage of the story so far points to:

  • Annual recurring revenue (ARR) was $1.94bn, up 12% year-on-year.

  • Net retention rate was 109%, meaning that the average customer spend was 9% higher than the year-ago quarter.

  • Continued reporting by CMC Markets as more details emerge

Advertisement
Robotics Path Stock Can 2026 Updates

More in Robotics

View all →